Consensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease.
Pignotti MS, Carmela Leo M, Pugi A, De Masi S, Biermann KP, Galli L, Vitali Rosati G, Buonocore G, Mugelli A, Dani C, Lucenteforte E, Bellini F, Donzelli G; Palivizumab Consensus Group.
Pignotti MS, et al.
Pediatr Pulmonol. 2016 Oct;51(10):1088-1096. doi: 10.1002/ppul.23561. Epub 2016 Sep 12.
Pediatr Pulmonol. 2016.
PMID: 27618642
Review.